DEVELOPING ANTI-MARCKS TECHNOLOGIES

PIPELINE

Bio-11006 COPD  Phase 2
Bio-11006 NSCLC  Preclinical Preclinical  Phase 2  Phase 2
Bio-11006 ARDS  Preclinical  Preclinical  Phase 2  Phase 2
Bio-11002 Pediatric Cancer Phase 1-2